Bright Minds Biosciences's total assets for Q4 2023 were C$6.88M, a decrease of -40.44% from the previous quarter. DRUG total liabilities were C$280.86K for the fiscal quarter, a -51.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.